Cholestatic & Autoimmune Liver Disease · Special Interest Group
Advancing Care in Cholestatic and Autoimmune Liver Disease
A clinician-led Special Interest Group dedicated to evidence-based diagnosis, management, and research in cholestatic and autoimmune liver diseases for practising physicians.
0
Members
0
Sessions scheduled
0
Sessions delivered
Office bearers
Led by the clinicians shaping the field.
Dr. Bilal Bobat
Chair
FCP cert Gastro · Liver Transplant
Dr. Kenan Moral
Vice-Chair
Lokman Hekim University · Liver Transplant
Prof. Sanjaya Satapathy
Secretary
MBBS, MD, DM, MS, FAASLD, FACG, AGAF, FASGE · Transplant Hepatology
Why this SIG, right now
Cholestatic and autoimmune liver diseases span a complex and evolving landscape. Practising clinicians need timely, evidence-grounded resources to navigate diagnosis, therapeutics, and long-term management with confidence.
01
A Rapidly Evolving Treatment Landscape
The therapeutic options available for conditions such as primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis have expanded considerably in recent years. Staying current with emerging agents and integrating them appropriately into practice requires ongoing engagement with the evidence base.